Stockchase Opinions

David FingoldCampbell Soup CompanyCPBCOMMENTOct 24, 2017

In the consumer staple sector. There is a reduction in barriers to entry within packaged foods. He would rather be in flavouring companies, such as Fruteron (?).

$46.13

Stock price when the opinion was issued

$21.11

As of May 29, 2026. Market Open.

food processing
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY
Good price for long-term hold?

People are moving away from ultra-processed foods with high salt content. Look at the business itself -- go-to products from 1960-70s are getting very tired. Costs up, profits down. FCF actually lower than in 2022. WACC is higher than ROIC, not good.

Not going to go bankrupt, so dividend probably won't get cut. You may be getting a 7% dividend yield as income, but you've watched your stock price drop 40% in the last year. Not for him, but you have to make your own decision on that.

If already owned, could use it for tax-loss selling.

PAST TOP PICK
(A Top Pick Jun 20/25, Down 30%)

They also sell snacks which was part of the growth story, but the growth story didn't work. He has an exit strategy for stocks, especially top picks. His reduce price was $29 and he sold at a loss. Investors should not keep holding losing stocks and should have an exit strategy. 

TOP PICK

He's starting to see some good volume around the price level right now, potential bottoming. Trying to get out of soup. Acquiring some snack companies. Has the potential and the desire to turn around, though that will take a while. Good value right now. Yield is 4.89%.

Doesn't own yet, but plans to buy with proceeds from sale of other US stocks. Start with only a small position today. If it drops below $29, start reducing.

(Analysts’ price target is $37.45)
DON'T BUY

They just reported and today held their investors' call. They say that high prices are scaring away customers with spending starting to slow last January. There was weakenss in crackers and chips. Not helping are the new 50% tariffs on steel and aluminum, precisely what Campbell soup cans are made of. The company blames general economic weakness, but don't mention the GLP-1 drug. The latter makes sense, not general economic weakness. CPB pays a safe 4.5% dividend, but no, it isn't worth getting paid to wait, not with the weight-loss drugs still selling.

DON'T BUY

It reports Monday. Trades at 11x PE and pays a 4% dividend, but gross margins have been squeezed due to higher costs--from tariffs. Meanwhile, the weight-loss drugs make you feel full, another headwind.

DON'T BUY

Their product line is very mature and offers little growth. This has been a sideways stock. Their snacks business is doing well, but not a growth driver. Either the stock declines and the dividend rises, or they buy another company.

BUY ON WEAKNESS

Will buy Sovos Brands for $2.7 billion all cash. Makes sense, giving Campbell's a growth engine at a time when the stock is out of favour, down 22% YTD. Buy this dip.

BUY ON WEAKNESS

Strong performance lately.
Excellent brand name with mature assets.
Defensive name that won't see major growth.

BUY
Up 31% this year so far. They've always had strong brands. They had supply chain problems this year, but thankfully are in the past. They raised prices to offset shortages and won't lower prices now that supplies problems have ended. Last week they reported a monster earnings beat, 15% organic sales growth and a strong forecast. Looks very good for 2023.
BUY
He recommends packaged food stocks as safe havens if there's a recession. CPB is up 22% this year. They keep putting up good numbers and just reported a 14-cent earnings beat, higher than expected sales (15% organic growth vs. expected 10%), and they raised their full-year forecast. There's more room to run.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Nov 12/20, Down 12.4%)Stockchase Research Editor: Michael O’Reilly Our PAST TOP PICK with CPB has triggered its stop at $42. To remain disciplined, we recommend covering the position at this time. This will result in a net investment loss of 12%, when combined with the previous buy recommendation.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Nov 12/20, Down 4.1%)Stockchase Research Editor: Michael O'Reilly To ensure progressing capital returns of our PAST TOP PICK with CPB, we recommend trailing the stop (from $38) to $42.
COMMENT
When investors fear the pandemic and a Fed-induced slowdown, the more conservative ones buy consumer staples. Staples have been beaten up this year, but today they rallied. Campbell's is up 8% so far this month, despite last week's mixed quarter. Yesterday, they held an investor day and unveiled very bullish long-term growth targets. Could this be the start of a larger move?
DON'T BUY
It reported this week, stating that it's struggling with raw costs and sales growth. The stock is cheap, but not cheap enough to buy, unless management can convince. He isn't holding his breath. They hold an investors' day on Tuesday.
COMMENT
It reports Wednesday. Unsteady soup sales and climbing costs could pressure the stock, like it has before.